Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51057

1.

Adenocarcinoma is not always the diagnosis - colon neoplasia in patient with long-standing ulcerative colitis under long-term prednisone maintenance therapy.

Costa JM, Rodrigues AP, Fernandes D, Costeira F, Vieira F, Gonçalves R, Teixeira M, Soares JB.

Clin Res Hepatol Gastroenterol. 2018 Dec 12. pii: S2210-7401(18)30270-5. doi: 10.1016/j.clinre.2018.11.013. [Epub ahead of print] No abstract available.

PMID:
30553755
2.

[First-line treatment of multiple myeloma].

Breitkreutz I, Raab M, Goldschmidt H.

Internist (Berl). 2018 Dec 14. doi: 10.1007/s00108-018-0527-x. [Epub ahead of print] Review. German.

PMID:
30552458
3.

Dexamethasone versus prednisone for children receiving asthma treatment in the paediatric inpatient population: protocol for a feasibility randomised controlled trial.

Pound CM, McDonald J, Tang K, Seidman G, Jetty R, Zaidi S, Plint AC.

BMJ Open. 2018 Dec 14;8(12):e025630. doi: 10.1136/bmjopen-2018-025630.

4.

Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas.

Merli M, Frigeni M, Alric L, Visco C, Besson C, Mannelli L, Di Rocco A, Ferrari A, Farina L, Pirisi M, Piazza F, Loustaud-Ratti V, Arcari A, Marino D, Sica A, Goldaniga M, Rusconi C, Gentile M, Cencini E, Benanti F, Rumi MG, Ferretti VV, Grossi P, Gotti M, Sciarra R, Tisi MC, Cano I, Zuccaro V, Passamonti F, Arcaini L.

Oncologist. 2018 Dec 14. pii: theoncologist.2018-0331. doi: 10.1634/theoncologist.2018-0331. [Epub ahead of print]

PMID:
30552159
5.

TCF7L2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/EGFR/Ras/Raf/MEK/ERK pathway.

Zhao Q, Zhao S, Li J, Zhang H, Qian C, Wang H, Liu J, Zhao Y.

Biomed Pharmacother. 2019 Jan;109:1640-1649. doi: 10.1016/j.biopha.2018.10.046. Epub 2018 Nov 16.

PMID:
30551418
6.

Clinical characterization of colitis arising from anti-PD-1 based therapy.

Wang DY, Mooradian MJ, Kim D, Shah NJ, Fenton SE, Conry RM, Mehta R, Silk AW, Zhou A, Compton ML, Al-Rohil RN, Lee S, Voorhees AL, Ha L, McKee S, Norrell JT, Mehnert J, Puzanov I, Sosman JA, Chandra S, Gibney GT, Rapisuwon S, Eroglu Z, Sullivan R, Johnson DB.

Oncoimmunology. 2018 Oct 31;8(1):e1524695. doi: 10.1080/2162402X.2018.1524695. eCollection 2019.

PMID:
30546965
7.

Severe Recurrent Necrotizing Myopathy in Pregnancy: A Case Report.

Li Y, Meng L, Yuan Y, Meng L, Lin J, Bu B.

Front Neurol. 2018 Nov 28;9:1028. doi: 10.3389/fneur.2018.01028. eCollection 2018.

8.

Ruxolitinib in combination with prednisone and nilotinib exhibit synergistic effects in human cells lines and primary cells from myeloproliferative neoplasms.

Arenas Cortés A, Ayala Diaz R, Hernández-Campo P, Gorrochategui J, Primo D, Robles A, Morales ML, Ballesteros J, Rapado I, Gallardo M, Linares M, Martínez-López J.

Haematologica. 2018 Dec 13. pii: haematol.2018.201038. doi: 10.3324/haematol.2018.201038. [Epub ahead of print]

9.

Adjusted Chemotherapy According to Frailty Status in Elderly Patients With Diffuse Large B-Cell Lymphoma: Experience From a Single Referral Center in Mexico City.

Lastra-German IK, Navarrete-Reyes AP, Mejía-Domínguez NR, Agreda-Vásquez GP.

Clin Lymphoma Myeloma Leuk. 2018 Nov 17. pii: S2152-2650(18)31211-4. doi: 10.1016/j.clml.2018.11.013. [Epub ahead of print]

PMID:
30545670
10.

Primary extra-nodal non-Hodgkin lymphoma in buttock soft tissue: A rare case report.

Li XM, Zhang HS, Dai XL, Shi JH.

Medicine (Baltimore). 2018 Dec;97(49):e13550. doi: 10.1097/MD.0000000000013550.

11.

Primary cutaneous anaplastic large cell lymphoma arising from a long-standing erythema nodosum: A case report.

Ma LL, Han SX, Fang MY.

Medicine (Baltimore). 2018 Dec;97(49):e13211. doi: 10.1097/MD.0000000000013211.

12.

Secondary skin involvement in gastric diffuse large B-cell lymphoma treated with chidamide: A case report.

Yang D, Zhang WP, Yang JM, He MX, Cheng C, Chen J.

Medicine (Baltimore). 2018 Dec;97(49):e13093. doi: 10.1097/MD.0000000000013093.

13.

Fulminant Vascular and Cardiac Toxicity Associated with Tyrosine Kinase Inhibitor Sorafenib.

Sudasena D, Balanescu DV, Donisan T, Hassan S, Palaskas N, Kim P, Karimzad K, Lopez-Mattei J, Arain S, Gould KL, Iliescu C.

Cardiovasc Toxicol. 2018 Dec 12. doi: 10.1007/s12012-018-9499-2. [Epub ahead of print]

PMID:
30543051
14.

Paraneoplastic syndrome - a rare but treatable cause of non-thyroid-related extraocular muscle enlargement.

Kumar S, Diamond T.

Orbit. 2018 Dec 7:1-6. doi: 10.1080/01676830.2018.1550790. [Epub ahead of print]

PMID:
30523726
15.

Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy.

Sha C, Barrans S, Cucco F, Bentley MA, Care MA, Cummin T, Kennedy H, Thompson JS, Uddin R, Worrillow L, Chalkley R, van Hoppe M, Ahmed S, Maishman T, Caddy J, Schuh A, Mamot C, Burton C, Tooze R, Davies A, Du MQ, Johnson PWM, Westhead DR.

J Clin Oncol. 2018 Dec 3:JCO1801314. doi: 10.1200/JCO.18.01314. [Epub ahead of print]

PMID:
30523719
16.

Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.

Ennishi D, Jiang A, Boyle M, Collinge B, Grande BM, Ben-Neriah S, Rushton C, Tang J, Thomas N, Slack GW, Farinha P, Takata K, Miyata-Takata T, Craig J, Mottok A, Meissner B, Saberi S, Bashashati A, Villa D, Savage KJ, Sehn LH, Kridel R, Mungall AJ, Marra MA, Shah SP, Steidl C, Connors JM, Gascoyne RD, Morin RD, Scott DW.

J Clin Oncol. 2018 Dec 3:JCO1801583. doi: 10.1200/JCO.18.01583. [Epub ahead of print]

PMID:
30523716
17.

Narrative review of therapies for chronic enteropathies in dogs and cats.

Makielski K, Cullen J, O'Connor A, Jergens AE.

J Vet Intern Med. 2018 Dec 6. doi: 10.1111/jvim.15345. [Epub ahead of print] Review.

18.

Granuloma annulare development in a patient with rheumatoid arthritis treated with tocilizumab: case-based review.

Pelechas E, Papoudou-Bai A, Voulgari PV, Drosos AA.

Rheumatol Int. 2018 Dec 7. doi: 10.1007/s00296-018-4212-0. [Epub ahead of print] Review.

PMID:
30523477
19.

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.

Horwitz S, O'Connor OA, Pro B, Illidge T, Fanale M, Advani R, Bartlett NL, Christensen JH, Morschhauser F, Domingo-Domenech E, Rossi G, Kim WS, Feldman T, Lennard A, Belada D, Illés Á, Tobinai K, Tsukasaki K, Yeh SP, Shustov A, Hüttmann A, Savage KJ, Yuen S, Iyer S, Zinzani PL, Hua Z, Little M, Rao S, Woolery J, Manley T, Trümper L; ECHELON-2 Study Group.

Lancet. 2018 Dec 3. pii: S0140-6736(18)32984-2. doi: 10.1016/S0140-6736(18)32984-2. [Epub ahead of print]

PMID:
30522922
20.

Corticosteroid use and increased CXCR2 levels on leukocytes are associated with lumacaftor/ivacaftor discontinuation in cystic fibrosis patients homozygous for the F508del CFTR mutation.

Pohl K, Nichols DP, Taylor-Cousar JL, Saavedra MT, Strand MJ, Nick JA, Bratcher PE.

PLoS One. 2018 Dec 12;13(12):e0209026. doi: 10.1371/journal.pone.0209026. eCollection 2018.

Supplemental Content

Loading ...
Support Center